


Healthcare Industry News: HSMN NewsFeed
News Release - November 20, 2014
Breckenridge Announces Appointment of New President
BOCA RATON, Fla., Nov. 20, 2014 -- (Healthcare Sales & Marketing Network) -- Breckenridge Pharmaceutical, Inc. announced the appointment of Larry Lapila to the position of President. Lapila previously served as Executive Vice President and has been with the company since 2001.Lapila succeeds Laurence D. (Larry) Runsdorf, who recently left his role as President and CEO, a role he filled since founding the company in 1983. Mr. Runsdorf will continue to work with the company on expansion strategies, and will remain on its Board of Directors.
About Breckenridge
Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products in many therapeutic categories. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. Breckenridge markets in excess of fifty (50) products in a variety of dosage forms and therapeutic categories. www.bpirx.com
Source: Breckenridge Pharmaceutical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
